Back to Journals » OncoTargets and Therapy » Volume 11

Review

Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML

       
Total article views   HTML views PDF downloads Totals
14,275 Dovepress* 8,900+ 1,293 10,193
PubMed Central* 5,375 842 6,217
Totals 14,275 2,135 16,410
*Since 12 June 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar